WUXI BIOLOGICS (Germany) Today
| 1FW1 Stock | EUR 6.15 0.20 3.15% |
PerformanceGood
| Odds Of DistressLow
|
WUXI BIOLOGICS is trading at 6.15 as of the 23rd of March 2025. This is a 3.15% down since the beginning of the trading day. The stock's lowest day price was 6.15. WUXI BIOLOGICS has less than a 10 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
WuXi Biologics Inc., an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the Peoples Republic of China, North America, Europe, and internationally. The company has 2.11 B outstanding shares. More on WUXI BIOLOGICS UNSPADR2
Moving together with WUXI Stock
Moving against WUXI Stock
WUXI Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. WUXI BIOLOGICS's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding WUXI BIOLOGICS or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
WUXI BIOLOGICS UNSPADR2 (1FW1) is traded on Frankfurt Exchange in Germany and employs 10,593 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 32.39 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate WUXI BIOLOGICS's market, we take the total number of its shares issued and multiply it by WUXI BIOLOGICS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. WUXI BIOLOGICS UNSPADR2 operates under Healthcare sector and is part of Biotechnology industry. The entity has 2.11 B outstanding shares.
WUXI BIOLOGICS UNSPADR2 has accumulated about 8.48 B in cash with 1.88 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.15.
Check WUXI BIOLOGICS Probability Of Bankruptcy
Ownership AllocationWUXI BIOLOGICS UNSPADR2 retains a total of 2.11 Billion outstanding shares. Roughly 99.99 (%) of WUXI BIOLOGICS outstanding shares are held by general public with 0.007 percent by institutional investors. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check WUXI Ownership Details
WUXI BIOLOGICS UNSPADR2 Risk Profiles
Although WUXI BIOLOGICS's alpha and beta are two of the key measurements used to evaluate WUXI BIOLOGICS's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.89 | |||
| Semi Deviation | 2.88 | |||
| Standard Deviation | 4.27 | |||
| Variance | 18.21 |
WUXI Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in WUXI BIOLOGICS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Other Information on Investing in WUXI Stock
WUXI BIOLOGICS financial ratios help investors to determine whether WUXI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WUXI with respect to the benefits of owning WUXI BIOLOGICS security.